Étude d’un nouveau traceur théranostique pour le cancer de la prostate : 64CU-DOTHA2-PSMA

Vidéo:

Description

(English translation will be available soon)
Laureate Symposium 2020: Preclinical evaluation of 64Cu-DOTHA2-PSMA-617 for theranosticsin prostate cancer

Speakers

Ophélie Bélissant Benesty, Jean-Noël Talbot (Hôpital Tenon, Paris), Éric Turcotte (Centre hospitalier universitaire de Sherbrooke, Québec)

Share this article

Speakers

Ophélie Bélissant Benesty, Jean-Noël Talbot (Hôpital Tenon, Paris), Éric Turcotte (Centre hospitalier universitaire de Sherbrooke, Québec)

Others publications

Oncology

Lung cancers

Authors : Marie Wislez, Hôpital Cochin AP-HP, Paris Descartes, Paris, France

Oncology

Development of new sequences in ultra-high field resolution (7T) MRI, and clinical validation in ophthalmologic oncology

Authors : Augustin Lecler, Jean-Claude Sadik (Fondation Rothchild, Paris) Brian Rutt (Center of Imaging, Stanford)

Immunology

Intestinal microbiota and its host: harmony or discord?

Authors : Pr François Bricaire, Dr Béatrice Guardiola

Iron overload

Iron overload and haemolytic anaemia

Author : Frédéric Galacteros